Patients with asthma and allergic bronchopulmonary aspergillosis experienced improvements with dupilumab, according to data presented at the American Thoracic Society International Conference.Quality ...

Dupilumab use in asthma linked to higher lymphoma risk, especially T/NK cell types, though overall mortality was lower, new ...

Dupilumab in combination with other biologic agents is safe and effective for treating various chronic inflammatory conditions.

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...

In the trial, Dupixent ® (dupilumab) outperformed Xolair ® (omalizumab) on all primary and secondary efficacy endpoints of CRSwNP, and in all asthma-related endpoints.

Biological drugs have improved the lives of many people with severe asthma. However, a new study from Karolinska Institutet ...

Dupilumab improved nasal polyp outcomes and asthma symptoms more than omalizumab in patients with CRSwNP and asthma, according to the head-to-head EVEREST phase 4 trial.

Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...

Biologics, including medications like mepolizumab and dupilumab, are widely prescribed for patients with severe asthma and ...

The association between dupilumab and psoriasis was further supported by validation in patients with asthma without atopic dermatitis.

In a study published in Allergy, titled "High-Dimensional Analysis of Type 2 Lymphocyte Dynamics During Mepolizumab or Dupilumab Treatment in Severe Asthma," researchers at Karolinska Institutet have ...